HAEMONETICS CORP — Director's Dealing 2019

Sep 11, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2019-09-09

Reporting Person: Scanlan Jacqueline (SVP, Global Human Resources)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-09-09	Common Stock	M	1308	$93.52	Acquired	6226	Direct
2019-09-09	Common Stock	S	1531	$127.44	Disposed	4695	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-09-09	Non-qualified Stock Option (Right to Buy)	$93.52	M	1308	Disposed	2025-06-11	Common Stock (1308)	Direct

Footnotes

F1: Transaction pursuant to an existing 10b5-1 trading plan.

F2: This number includes unvested restricted stock units previously reported.

F3: Option vests in annual increments of 25% beginning on the first anniversary of the date of grant.